Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design-Reference-Cited by-同舟云学术

Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design

Published:2013-04 Issue:4 Volume:45 Page:908-915
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Izumi Kazuki,Kawaji Kumi,Miyamoto Fusasko,Shimane Kazuki,Shimura Kazuya,Sakagami Yasuko,Hattori Toshio,Watanabe Kentaro,Oishi Shinya,Fujii Nobutaka,Matsuoka Masao,Kaku Mitsuo,Sarafianos Stefan G.,Kodama Eiichi N.

Funder

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Ministry of Health, Labour and Welfare

National Institute of Health (NIH)

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference50 articles.

1. Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment;Aquaro;Journal of Antimicrobial Chemotherapy,2006

2. HIV-1 resistance to the gp41-dependent fusion inhibitor C-34;Armand-Ugon;Antiviral Research,2003

3. Impact of the enfuvirtide resistance mutation N43D and the associated baseline polymorphism E137K on peptide sensitivity and six-helix bundle structure;Bai;Biochemistry,2008

4. Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor;Baldwin;Journal of Virology,2004

5. Covalent stabilization of coiled coils of the HIV gp41N region yields extremely potent and broad inhibitors of viral infection;Bianchi;Proceedings of the National Academy of Sciences of the United States of America,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Helix-based screening with structure prediction using artificial intelligence has potential for the rapid development of peptide inhibitors targeting class I viral fusion;RSC Chemical Biology;2024

2. HIV-1 gp41 genetic diversity and enfuvirtide resistance-associated mutations among enfuvirtide-naïve patients in southern China;Virus Research;2021-01

3. Prospects for Foamy Viral Vector Anti-HIV Gene Therapy;Biomedicines;2016-03-29

4. Coronaviruses — drug discovery and therapeutic options;Nature Reviews Drug Discovery;2016-02-12

5. Anti-HIV-1 activity determined by β-galactosidase activity in the multinuclear activation of an indicator assay is comparable with that by a conventional focus counting method;Antiviral Chemistry and Chemotherapy;2015-04